Accendra Health (ACH) Total Non-Current Liabilities (2009 - 2026)
Accendra Health (ACH) reported Total Non-Current Liabilities of $2.8 billion for Q1 2026, down 33.48% year-over-year from $4.2 billion in Q1 2025, and down 0.88% quarter-over-quarter from $2.8 billion in Q4 2025.
Accendra Health (ACH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Accendra Health (ACH) has 18 years of Total Non-Current Liabilities data on file, last reported at $2.8 billion in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $2.8 billion, down 33.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 billion (down 33.48% YoY), and the FY2025 annual result was $2.8 billion, down 29.52% from the prior year.
- Total Non-Current Liabilities declined to $2.8 billion in Q1 2026 per ACH's latest filing, from $2.8 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $4.6 billion in Q1 2022 and troughed at $2.8 billion in Q1 2026.
- A 5-year average of $4.1 billion and a median of $4.3 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities surged 84.81% in 2022, then sank 33.48% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $4.3 billion in 2022, then decreased by 3.63% to $4.2 billion in 2023, then declined by 4.11% to $4.0 billion in 2024, then decreased by 29.52% to $2.8 billion in 2025, then slipped by 0.88% to $2.8 billion in 2026.
- Business Quant data shows ACH's Total Non-Current Liabilities at $2.8 billion in Q1 2026, $2.8 billion in Q4 2025, and $4.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.72 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.37 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 329.13 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 6.05 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.79 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 58.52 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 279.68 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 40.66 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Bn |
| Dec 31, 2025 | 2.82 Bn |
| Sep 30, 2025 | 4.38 Bn |
| Jun 30, 2025 | 4.35 Bn |
| Mar 31, 2025 | 4.20 Bn |
| Dec 31, 2024 | 4.00 Bn |
| Sep 30, 2024 | 4.09 Bn |
| Jun 30, 2024 | 4.33 Bn |
| Mar 31, 2024 | 4.19 Bn |
| Dec 31, 2023 | 4.17 Bn |
| Sep 30, 2023 | 4.12 Bn |
| Jun 30, 2023 | 4.27 Bn |
| Mar 31, 2023 | 4.26 Bn |
| Dec 31, 2022 | 4.33 Bn |
| Sep 30, 2022 | 4.45 Bn |
| Jun 30, 2022 | 4.46 Bn |
| Mar 31, 2022 | 4.62 Bn |
| Dec 31, 2021 | 2.49 Bn |
| Sep 30, 2021 | 2.58 Bn |
| Jun 30, 2021 | 2.64 Bn |